These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 21194567

  • 1. Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts.
    Eggenhofer E, Steinmann JF, Renner P, Slowik P, Piso P, Geissler EK, Schlitt HJ, Dahlke MH, Popp FC.
    Transpl Immunol; 2011 Apr 15; 24(3):157-63. PubMed ID: 21194567
    [Abstract] [Full Text] [Related]

  • 2. Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model.
    Eggenhofer E, Renner P, Soeder Y, Popp FC, Hoogduijn MJ, Geissler EK, Schlitt HJ, Dahlke MH.
    Transpl Immunol; 2011 Sep 15; 25(2-3):141-7. PubMed ID: 21704160
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil.
    Blaheta RA, Leckel K, Wittig B, Zenker D, Oppermann E, Harder S, Scholz M, Weber S, Schuldes H, Encke A, Markus BH.
    Transpl Immunol; 1998 Dec 15; 6(4):251-9. PubMed ID: 10342739
    [Abstract] [Full Text] [Related]

  • 4. Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate.
    Popp FC, Eggenhofer E, Renner P, Slowik P, Lang SA, Kaspar H, Geissler EK, Piso P, Schlitt HJ, Dahlke MH.
    Transpl Immunol; 2008 Nov 15; 20(1-2):55-60. PubMed ID: 18762258
    [Abstract] [Full Text] [Related]

  • 5. Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection.
    Klupp J, van Gelder T, Dambrin C, Regieli JJ, Boeke K, Billingham ME, Morris RE.
    J Heart Lung Transplant; 2004 Mar 15; 23(3):334-51. PubMed ID: 15019644
    [Abstract] [Full Text] [Related]

  • 6. Effects of mycophenolic acid mofetil on acute rejection of kidney allografts in rats.
    Heemann U, Azuma H, Schmid C, Philipp T, Tilney N.
    Clin Nephrol; 1996 May 15; 45(5):355-7. PubMed ID: 8738672
    [Abstract] [Full Text] [Related]

  • 7. Mesenchymal stem cells require a sufficient, ongoing immune response to exert their immunosuppressive function.
    Renner P, Eggenhofer E, Rosenauer A, Popp FC, Steinmann JF, Slowik P, Geissler EK, Piso P, Schlitt HJ, Dahlke MH.
    Transplant Proc; 2009 May 15; 41(6):2607-11. PubMed ID: 19715984
    [Abstract] [Full Text] [Related]

  • 8. [The influence of mycophenolate mofetil upon the maturation and allostimulatory activity of cultured dendritic cell progenitors and the effects of tolerance induction in allograft recipients].
    Han CH, Li HF, Wang YX, Zhang M, Wang Y, Yin M, Min ZL, Zheng KL.
    Zhonghua Yi Xue Za Zhi; 2005 May 25; 85(19):1327-32. PubMed ID: 16029632
    [Abstract] [Full Text] [Related]

  • 9. The immunosuppressive drug mycophenolate mofetil impairs the adhesion capacity of gastrointestinal tumour cells.
    Leckel K, Beecken WD, Jonas D, Oppermann E, Coman MC, Beck KF, Cinatl J, Hailer NP, Auth MK, Bechstein WO, Shipkova M, Blaheta RA.
    Clin Exp Immunol; 2003 Nov 25; 134(2):238-45. PubMed ID: 14616783
    [Abstract] [Full Text] [Related]

  • 10. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model.
    Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, Geissler EK, Dahlke MH.
    Transplantation; 2006 Jun 15; 81(11):1589-95. PubMed ID: 16770249
    [Abstract] [Full Text] [Related]

  • 11. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
    Wang H, Qi F, Dai X, Tian W, Liu T, Han H, Zhang B, Li H, Zhang Z, Du C.
    Transpl Immunol; 2014 Aug 15; 31(2):65-74. PubMed ID: 24978830
    [Abstract] [Full Text] [Related]

  • 12. Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation.
    Lohan P, Murphy N, Treacy O, Lynch K, Morcos M, Chen B, Ryan AE, Griffin MD, Ritter T.
    Front Immunol; 2018 Aug 15; 9():2666. PubMed ID: 30515159
    [Abstract] [Full Text] [Related]

  • 13. Effect of mycophenolate mofetil on rat kidney grafts with prolonged cold preservation.
    Fuller TF, Hoff U, Rose F, Linde Y, Freise CE, Dragun D, Feng S.
    Kidney Int; 2006 Aug 15; 70(3):570-7. PubMed ID: 16788694
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of monocyte/endothelial cell interactions and monocyte adhesion molecule expression by the immunosuppressant mycophenolate mofetil.
    Glomsda BA, Blaheta RA, Hailer NP.
    Spinal Cord; 2003 Nov 15; 41(11):610-9. PubMed ID: 14569262
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts.
    Heemann U, Azuma H, Hamar P, Schmid C, Tilney N, Philipp T.
    Transpl Immunol; 1996 Mar 15; 4(1):64-7. PubMed ID: 8762015
    [Abstract] [Full Text] [Related]

  • 16. Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo.
    Rentenaar RJ, van Diepen FN, Meijer RT, Surachno S, Wilmink JM, Schellekens PT, Pals ST, van Lier RA, ten Berge IJ.
    Kidney Int; 2002 Jul 15; 62(1):319-28. PubMed ID: 12081594
    [Abstract] [Full Text] [Related]

  • 17. Combination effect of mycophenolate mofetil with mizoribine on cell proliferation assays and in a mouse heart transplantation model.
    Shimmura H, Tanabe K, Habiro K, Abe R, Toma H.
    Transplantation; 2006 Jul 27; 82(2):175-9. PubMed ID: 16858279
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection.
    Barten MJ, van Gelder T, Gummert JF, Boeke K, Shorthouse R, Billingham ME, Morris RE.
    Am J Transplant; 2002 Sep 27; 2(8):719-32. PubMed ID: 12243493
    [Abstract] [Full Text] [Related]

  • 19. A short course of mycophenolate immunosuppression inhibits rejection, but not tolerance, of rat liver allografts in association with inhibition of interleukin-4 and alloantibody responses.
    Huang WH, Yan Y, Li J, De Boer B, House AK, Bishop GA.
    Transplantation; 2003 Oct 27; 76(8):1159-65. PubMed ID: 14578746
    [Abstract] [Full Text] [Related]

  • 20. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H, Leamer M, Wang HK, Makowka L, Cramer DV.
    Transplantation; 1995 Feb 15; 59(3):401-10. PubMed ID: 7871571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.